美股异动 | 与礼来(LLY.US)、诺和诺德(NVO.US)合作直供GLP-1减重药 Mangoceuticals(MGRX.US)盘前飙升约19%

Core Viewpoint - Mangoceuticals (MGRX.US) stock price surged approximately 19% following the announcement of partnerships with pharmaceutical giants Eli Lilly (LLY.US) and Novo Nordisk (NVO.US) to directly offer their popular GLP-1 weight loss medications [1] Company Summary - Mangoceuticals, based in Dallas, Texas, has launched the MangoRx Direct and PeachesRx Direct platforms aimed at self-paying users [1] - The platforms will sell Eli Lilly's Zepbound (tirzepatide) and Novo Nordisk's Wegovy (semaglutide) directly to consumers [1]